Perrigo Co (NASDAQ:PRGO)
| 118.92 Data as of May 24 |  +1.06 / +0.90%Today’s Change | 98.79 Today|||52-Week Range 121.33 | +14.31% Year-to-Date |
PRGO Regular Dividend: PRGO will begin trading ex-dividend on 05/29/13 with a $0.09 dividend payable to shareholders of record as of 05/31/13.
Latest PRGO News | Press Releases
No recent news for Perrigo Co.
Today’s Trading
| Previous close | 117.86 |
| Today’s open | 117.35 |
| Day’s range | 116.67 - 119.13 |
| Volume | 403,796 |
| Average volume (3 months) | 507,831 |
| Market cap | $11.2B |
| Dividend yield | 0.30% |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +17.63% |
| Earnings growth (this year) | +12.59% |
| Earnings growth (next 5 years) | +14.50% |
| Revenue growth (last year) | +15.13% |
| P/E ratio | 26.1 |
| Price/Sales | 3.46 |
| Price/Book | 6.01 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MYLMylan Inc | -0.57 | -1.81% |
| FRXForest Laboratories ... | -0.30 | -0.76% |
| BMRNBioMarin Pharmaceuti... | -1.37 | -2.08% |
| ONXXOnyx Pharmaceuticals... | -0.97 | -1.01% |
Data as of 4:03pm ET, 05/24/2013
Financials
| Next reporting date | August 20, 2013 |
| EPS forecast (this quarter) | $1.58 |
| Annual revenue (last year) | $3.2B |
| Annual profit (last year) | $401.6M |
| Net profit margin | 12.38% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Joseph C. Papa, MBA |
Executive VP-Global Operations & Supply Chain John T. Hendrickson |
Corporate headquarters Allegan, Michigan |
Forecasts
